144 results
Page 6 of 8
8-K
EX-99.1
hxz7mla534arxg i69
17 Dec 19
EyeGate Pharma Receives $1.9 Million From Exercised Warrants
8:41am
8-K
EX-99.1
6wyvmagahzzfn76 d02
2 Dec 19
EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
6:55am
8-K
EX-99.1
fsbcv55ua
22 Nov 19
Other Events
6:55am
CORRESP
88jascdbjkolzavdp
8 Nov 19
Correspondence with SEC
12:00am
UPLOAD
meyljhny vp1
31 Oct 19
Letter from SEC
12:00am
8-K
EX-10.1
h265lqx 33fqx50efc
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-99.1
ongmi6s59sl
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-99.1
qu599apu xxpy
23 Sep 19
Other Events
6:57am
8-K
EX-99.1
xrm3ms0
29 Aug 19
Material Modifications to Rights of Security Holders
12:45pm
8-K
EX-99.1
8yq sj7or0doju
14 May 19
EyeGate Pharma Receives Positive Nasdaq Listing Determination
6:55am
8-K
EX-99.1
10m28m9w2o kimr
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.2
iznfaum4qkmljvwbdc
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.1
bukmgczqyo1rpl0
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am
8-K
EX-10.1
g1w2iiq7z348b83z8a
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am
8-K
EX-99.1
n30gsb3r
25 Sep 18
EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
6:58am